RMTI — ROCKWELL MEDICAL, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1041024 ·
Last close
$6.61
Market Cap
$26.25M
52W High
$12.90
52W Low
$4.89
ADV30
27,905
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 19,122,000 | 3,111,000 | -1,374,000 | -2,324,000 | 57,084,000 | 10,631,000 | 23,949,000 |
| Jun 2026 | 17,780,000 | 3,243,000 | -1,061,000 | -1,172,000 | 56,526,000 | 10,519,000 | 21,441,000 |
| Mar 2026 | 17,336,000 | 2,897,000 | -1,480,000 | -1,605,000 | 57,423,000 | 9,609,000 | 21,566,000 |
| Dec 2025 | 18,346,000 | 3,878,000 | -398,000 | -554,000 | 57,145,000 | 10,711,000 | 20,164,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$2,678,000
Investing CF
$-2,984,000
Financing CF
$-2,673,000
CapEx
$-1,850,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.90
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-408,093,000
Inventory
$2,935,000
Receivables
$9,796,000
ST Investments
$11,910,000
EBIT TTM
$-4,524,000
Pretax Income TTM
$-5,655,000
Interest Exp TTM
$1,131,000
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$69,389,000
EBITDA
$-2,430,000
Free Cash Flow
$350,375
Enterprise Value
$18,880,832
Total Cash
$24,797,000
Total Debt
$13,933,000
Shares Out
3,971,968
Trailing EPS
$-1.43
Book Value
$9.38
ROE
-15.5%
ROA
-5.2%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 69,258,000 | -4,691,000 | -5,314,000 | 57,145,000 | 20,164,000 | 36,981,000 | -659,000 |
| Dec 2024 | 101,489,000 | 608,000 | -480,000 | 59,208,000 | 26,622,000 | 32,586,000 | 4,202,000 |
| Dec 2023 | 83,612,000 | -6,670,000 | -8,439,000 | 52,173,000 | 30,882,000 | 21,291,000 | -9,412,000 |
| Dec 2022 | 72,810,000 | -16,780,000 | -18,679,000 | 46,635,000 | 32,529,000 | 14,106,000 | -16,929,000 |
TTM Snapshot
Revenues TTM
$69,389,000
NetIncome TTM
$-5,084,000
OpCashFlow TTM
—
Assets (Latest)
$56,526,000
Forward EPS
$0.07
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ACET | Adicet Bio, Inc. | $26.03M | $2.78 | — |
| BETRF | BetterLife Pharma Inc. | $25.64M | $0.15 | — |
| MIRA | MIRA PHARMACEUTICALS, INC. | $26.89M | $0.64 | — |
| ABVC | ABVC BIOPHARMA, INC. | $25.36M | $0.94 | — |
| BIOE | Bio Essence Corp | $25.29M | $0.47 | — |
News headlines (Yahoo Finance, 1h cache)
Rockwell Medical, Inc. Q3 2026 Earnings Call Summary
2026-11-12 18:06 · Yahoo
Rockwell Medical (RMTI) Q3 2026 Earnings Call Transcript
2026-11-12 16:31 · Yahoo
Rockwell Medical: Q3 Earnings Snapshot
2026-11-12 11:10 · Yahoo
Rockwell Medical (RMTI) Reports Q3 Loss, Tops Revenue Estimates
2026-11-12 11:10 · Yahoo
Rockwell Medical Announces Third Quarter 2026 Results
2026-11-12 11:00 · Yahoo
Rockwell Medical stock surges on $125M Vantive acquisition deal
2026-11-03 15:26 · Yahoo
Vantive Announces Agreement to Divest Majority of Hemodialysis Assets and Associated Operations to Rockwell Medical
2026-11-03 11:01 · Yahoo
Rockwell Medical Announces Transformational Global Hemodialysis Acquisition
2026-11-03 11:00 · Yahoo
Rockwell Medical to Release Third Quarter 2026 Results on Thursday, November 12, 2026
2026-10-15 10:00 · Yahoo
Rockwell Medical to Exhibit at ASN Kidney Week 2026
2026-10-14 10:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.